BioNexus Gene Lab Corp. Shareholders' Equity
BioNexus Gene Lab Corp. (BGLC) had Shareholders' Equity of $7.78 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-14
- 2026-06-30: Stockholders' Equity Attributable to Parent $7.78M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $8.09M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $8.61M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $6.82M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $7.78M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $8.09M 10-Q · filed 2026-08-14 | |
| 2025-12-31 | $8.61M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $6.82M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $7.52M 10-Q · filed 2026-08-14 | |
| 2025-03-31 | $7.77M 10-Q · filed 2026-08-14 | |
| 2024-12-31 | $8.32M 10-Q · filed 2026-08-14 | |
| 2024-09-30 | $9.39M 10-Q · filed 2025-11-14 | |
| 2024-06-30 | $9.55M 10-Q · filed 2025-11-14 | |
| 2024-03-31 | $9.34M 10-Q · filed 2025-11-14 | |
| 2023-12-31 | $9.66M 10-K · filed 2026-04-14 | |
| 2023-09-30 | $9.32M 10-Q · filed 2024-11-15 | $9.69M 10-Q/A · filed 2024-03-26 |
| 2023-06-30 | $5.59M 10-Q · filed 2024-11-15 | $5.96M 10-Q · filed 2023-08-16 |
| 2023-03-31 | $6.19M 10-Q · filed 2024-11-15 | $6.56M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $6.67M 10-K · filed 2025-04-15 | |
| 2022-09-30 | $6.42M 10-Q/A · filed 2024-03-26 | |
| 2022-06-30 | $6.82M 10-Q/A · filed 2024-03-26 | |
| 2022-03-31 | $7.13M 10-Q/A · filed 2024-03-26 | |
| 2021-12-31 | $7.18M 10-K · filed 2024-04-16 | |
| 2021-09-30 | $7.05M 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $6.81M 10-Q · filed 2022-11-14 | |
| 2021-03-31 | $6.79M 10-Q · filed 2022-11-14 | |
| 2020-12-31 | $6.66M 10-K · filed 2023-03-31 | |
| 2020-09-30 | $6.68M 10-Q · filed 2021-11-15 | $931.59K 10-Q · filed 2020-11-03 |
| 2020-06-30 | $6.20M 10-Q · filed 2021-11-15 | $969.68K 10-Q · filed 2020-08-11 |
| 2020-03-31 | $6.19M 10-Q · filed 2021-11-15 | $1.03M 10-Q · filed 2020-05-08 |
| 2020-01-01 | $1.12M 10-K · filed 2022-04-06 | |
| 2019-12-31 | $1.12M 10-Q · filed 2021-11-15 | |
| 2019-09-30 | $1.26M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $1.39M 10-Q · filed 2019-11-14 | |
| 2019-03-31 | $1.48M 10-Q · filed 2019-11-14 | |
| 2018-12-31 | $1.52M 10-K · filed 2021-03-30 | |
| 2018-01-01 | $94.63K 10-K · filed 2020-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |